期刊文献+

霉酚酸酯对糖尿病大鼠肾组织中TGF-β1、p-Smad2/3表达的影响 被引量:1

Effect of Mycophenolate Mofetil on the Expression of p-Smad2/3 in Diabetic Rats
在线阅读 下载PDF
导出
摘要 【目的】观察霉酚酸酯(MMF)对糖尿病大鼠肾组织中转化生长因子-β1(TGF-β1),p-Smad2/3表达的影响,探讨MMF对糖尿病肾病的保护作用及其机制。【方法】36只雄性SD大鼠随机分为正常对照组,糖尿病模型组和MMF治疗组,行单侧肾脏切除术,以链脲佐菌素(STZ)腹腔内注射建立糖尿病大鼠模型,药物干预后第4,12周每组处死6只大鼠,测24h尿蛋白定量,HE,Masson染色观察肾脏组织学改变;免疫组织化学方法检测TGF-β1,p-Smad2/3在肾组织中的表达。【结果】正常对照组有少量TGF-β1和p-Smad2/3表达,模型组大鼠24h尿蛋白排泄量增多(P<0.05),系膜区基质增多,TGF-β1和p-Smad2/3表达均明显增强(P<0.05);MMF治疗组24h尿蛋白排泄量显著下降(P<0.05),肾组织TGF-β1和p-Smad2/3表达均有减少(P<0.05)。【结论】在糖尿病大鼠模型中,MMF能下调TGF-β1,p-Smad2/3的表达,减少蛋白尿,延缓肾脏纤维化的进展,从而达到对糖尿病肾病的保护作用。 [Objective] To observe the expressions of TGF-β1 and p-Smad2/3 in renal tissue of diabetic rats intervened by mycophenolate mofetil (MMF), and to assess the effects of MMF on diabetic nephropathy model in rats, and to explore its mechanism. [Methods]Thirty-six male Sprague-Dawley rats were randomly divided into three groups: normal control group, diabetic model group and MMF-treated group. SD rats were made diabetic by intraperitoneal injection of streptozotocin after uni-nephrectomy, and the control group only injected the sham solution. Six rats of each group were sacrificed at the 4th week, 12th week, and 24hr urinary protein count was measured before dead. Rena pathological changes were investigated by HE and Masson staining. The expressions of TGF-β1 and p-Smad2/3 protein in renal tissue were detected by immunohistochemistry. [Results] The expressions of TGF-β1 and p-Smad2/3 were little in normal renal tissue. In diabetic model group, they were obviously higher than normal control group at each time point( P 〈0.05), and 24hr urinary protein count increased significantly( P〈0.05). The above mentioned parameters were all significantly inhibited after treated by MMF at each time point( P 〈0.05). [Conclusion] There are increased expressions of TGF-β1 and p-Smad2/3 in kidney of STZ-induced diabetic rats. MMF probably has some protective effect on diabetic kidney by inhibiting the TGF-β-dependent Smad signal pathway.
出处 《医学临床研究》 CAS 2008年第4期598-600,603,共4页 Journal of Clinical Research
基金 湖南省自然科学基金(05JJ30059)
关键词 疾病模型 动物 霉酚酸/药理学 肾/病理学 肾/代谢 糖尿病/代谢 糖尿病/病理学 转化生长因子β/代谢 disease models, Animal mycophenolic acid/PD kidney/PA kidney/ME diabetes mellitus/PA diabetes mellitus/ME transforming growth factor beta/ME
作者简介 通讯作者,Email:zhanghaoliaoqing@163.com
  • 相关文献

参考文献14

  • 1Kanwar YS, Akagi S, Sun L, et al . Cell biology of diabetic kidney disease[J]. Nephron Exp Nephrol , 2005,101 (3) : e100.
  • 2Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta signaling[J]. Nature , 2003,425 (6958):577-584.
  • 3Isono M, Chen S, Hong SW, et al . Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF- beta-induced fibronectin in mesangial cells [J]. Biochem Biophys Commun ,2002,296(5) :1356-1365.
  • 4Utimura R, Kazue C, Fujihara CK, et al . Mycophenolate mofetil prevents the development of glomrular injury in experiment diabetes[J]. Kidney Int , 2003, 63:209-216.
  • 5Bayazit AK, Bayazit Y, Noyan A, et al . Comparison of mycophenolate mofetil and aaathioprine in obstructive nephropathy[J]. Pediatr Nephrol ,2003, 18(2): 100-104.
  • 6Yu HT. Progression of the chronic renal failure[J]. Arch Intern Med , 2003, 163(12) :1417-1429.
  • 7Bottingger EP, Bitzer M. TGF-β1 signaling in renal disease [J]. J Am Soc Nephrol , 2002, 13(10):2600-2610.
  • 8Massague RP. Transcriptional control by the TGF-β1/Smad signaling system[J]. EMBO , 2000,19:1745-1754.
  • 9Javelaud D, Mauviel A. Mammalian transforming growth factor-beta Smad signaling and physio-pathological role[J]. Int J Biochem Cell Biol ,2004, 36(7) : 1161-1165.
  • 10Becker BN. Mycophenolate mofetil[J]. Transplant Proc , 1999,31(7) : 2777-2778.

二级参考文献10

  • 1Alexopoulos E,Papagianni A,Papadimitriou M. Is membranous nephropathy only a glomerular disease? Renal Failure,1998,20:1-6.
  • 2Gregory CR,Pratt RE,Huie P,et al. Effect of treatment with cyclosporine,FK506,rapamycin,mycophenolic acid or desoxyspergualin on vascular musle proliferation in vitro and in vivo. Transplant Proc,1993,25:770-771.
  • 3Hiroyuki Kaneto,Jeremiah Morrissey,Ruth McCracken,et al. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed kidney. Kidney Int,1994,45:1637-1647.
  • 4EL Nahas AM. Pathways to renal fibrosis. Exp Nephrol,1995,3:71-75.
  • 5Gabbiani G,Zhao X,Riser BL et al.The biology of fibroblast. Kidney Int,1992,41:530-532.
  • 6Cherif Bandid ,Madeleine Vincent,Brightte Mc,et al. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney.Kidney Int,2000,58:51-61.
  • 7Freddy Romero,Bernardo Rodriguez-Iturbe,Gustavo Parra,et al. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int,1999,55:945-955.
  • 8Oemar BS,Foellmer HG,Hodgdon-Anandant L,et al.Regulation of insulin-like growth factor I receptors in diabetic mesangial cells.J Biol Chem,1991,266:2369-2373.
  • 9Dubus I,Vendrely B,Christophe I,et al.Mycophenolic acid antagonizes the activation of cultured human mesangial cells.Kidney Int,2002,62:857-867.
  • 10Nahman NS Jr,Leonhart KL,Cosio FG,et al.Effects of high glucose on proliferation and fibronectin production by cultured human mesangial cells.Kidney Int,1992,41:396-402.

共引文献8

同被引文献3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部